4-Methylmethylphenidate
4-Methylmethylphenidate is a stimulant research chemical structurally related to methylphenidate. It appeared briefly on the market in mid-2015 following bans on ethylphenidate and other phenidates. The substance is reported to be slightly less potent than methylphenidate, with relatively low efficacy at blocking dopamine reuptake despite high binding affinity. It has been described as producing functional stimulation with limited recreational effects and was investigated as a potential substitute treatment for stimulant abuse.
Contents
Dosage & Duration
Dosage
Duration
Subjective Effects
4-Methylmethylphenidate produces a predominantly functional stimulation reminiscent of ethylphenidate, with wakefulness, alertness, and increased energy as its core features. Its recreational character is inconsistent between users: many describe the experience as flat or lacking a rewarding edge, while a minority report euphoria and a distinctly recreational quality at higher doses. As a methylphenidate analogue, its overall profile aligns with that of the substituted phenidate stimulants rather than the entactogens or classical psychedelics.
Physical
Physical effects follow a standard stimulant pattern: increased energy, decreased need for sleep, appetite suppression, sweating, and bruxism. Itchiness, disturbed sleep patterns, and weight loss with repeated use have also been reported.
Stimulation
Uncomfortable
Cognitive
The headspace is stimulating and outwardly directed, with increased sociability, talkativeness, and mood lift reported alongside heightened alertness. Negative shifts in emotional tone, including moodiness, irritability, and aggressiveness, are also reported.
Emotional
Emotional effects are variable, ranging from mood lift and euphoria to irritability and moodiness.
Enhancements
Visual
Visual effects are not characteristic of ordinary use, though hallucinations have been reported.
Auditory
Auditory hallucinations have been reported.
Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
4-Methylmethylphenidate (4-MeTMP) is a stimulant structurally related to methylphenidate that acts on the dopamine transporter. It exhibits high binding affinity at the dopamine transporter but relatively low efficacy at blocking dopamine reuptake, making it slightly less potent than methylphenidate as a dopamine reuptake inhibitor.
Pharmacokinetics
Tolerance
Harm Potential
Addiction & Dependence
Psychological
LowClassified as habit-forming. Its relatively low efficacy at blocking dopamine reuptake despite high binding affinity led to its investigation as a possible substitute drug for treatment of stimulant abuse, suggesting potentially lower reinforcing effects compared to other stimulants.
Psychosis Risk
Visual and auditory hallucinations are listed among possible effects.
History & Culture
4-Methylmethylphenidate emerged on the designer stimulant market in mid-2015, appearing shortly after regulatory actions in the United Kingdom restricted ethylphenidate and other phenidate compounds. Its commercial availability as an unscheduled research chemical proved exceptionally brief, lasting…
Legality
By Country
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 4-Methylmethylphenidate article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.